Charles Schwab’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $104M | Buy |
1,322,613
+33,080
| +3% | +$2.26M | 0.01% | 781 |
|
|
2026
Q1 | $83.3M | Buy |
1,289,533
+47,704
| +4% | +$3.36M | 0.01% | 823 |
|
|
2025
Q4 | $83.6M | Sell |
1,241,829
-19,546
| -2% | -$1.31M | 0.01% | 816 |
|
|
2025
Q3 | $92.5M | Sell |
1,261,375
-81,456
| -6% | -$5.41M | 0.01% | 760 |
|
|
2025
Q2 | $69.9M | Sell |
1,342,831
-406,020
| -23% | -$23.1M | 0.01% | 882 |
|
|
2025
Q1 | $112M | Sell |
1,748,851
-34,326
| -2% | -$1.99M | 0.02% | 604 |
|
|
2024
Q4 | $85.3M | Buy |
1,783,177
+9,780
| +0.6% | +$501K | 0.02% | 753 |
|
|
2024
Q3 | $102M | Sell |
1,773,397
-14,151
| -0.8% | -$811K | 0.02% | 642 |
|
|
2024
Q2 | $93.6M | Buy |
1,787,548
+120,069
| +7% | +$5.27M | 0.02% | 678 |
|
|
2024
Q1 | $67.8M | Sell |
1,667,479
-68,643
| -4% | -$2.57M | 0.02% | 817 |
|
|
2023
Q4 | $64.2M | Buy |
1,736,122
+37,763
| +2% | +$1.42M | 0.02% | 804 |
|
|
2023
Q3 | $64.9M | Buy |
1,698,359
+15,902
| +0.9% | +$651K | 0.02% | 727 |
|
|
2023
Q2 | $60.7M | Sell |
1,682,457
-3,518
| -0.2% | -$120K | 0.02% | 747 |
|
|
2023
Q1 | $64.4M | Buy |
1,685,975
+72,969
| +5% | +$3.42M | 0.02% | 668 |
|
|
2022
Q4 | $91.8M | Buy |
1,613,006
+2,427
| +0.2% | +$124K | 0.03% | 512 |
|
|
2022
Q3 | $63.7M | Buy |
1,610,579
+352,662
| +28% | +$15.6M | 0.02% | 626 |
|
|
2022
Q2 | $55.3M | Sell |
1,257,917
-67,280
| -5% | -$2.91M | 0.02% | 689 |
|
|
2022
Q1 | $52.8M | Buy |
1,325,197
+30,582
| +2% | +$1.09M | 0.02% | 837 |
|
|
2021
Q4 | $52.1M | Sell |
1,294,615
-19,851
| -2% | -$741K | 0.02% | 865 |
|
|
2021
Q3 | $53.5M | Buy |
1,314,466
+85,223
| +7% | +$3.56M | 0.02% | 819 |
|
|
2021
Q2 | $55.8M | Buy |
1,229,243
+84,974
| +7% | +$3.76M | 0.02% | 791 |
|
|
2021
Q1 | $47.7M | Buy |
1,144,269
+198,156
| +21% | +$9.05M | 0.02% | 864 |
|
|
2020
Q4 | $40.4M | Sell |
946,113
-204
| -0% | -$7.33K | 0.02% | 915 |
|
|
2020
Q3 | $24.9M | Buy |
946,317
+51,156
| +6% | +$1.42M | 0.01% | 1060 |
|
|
2020
Q2 | $24M | Buy |
895,161
+46,547
| +5% | +$1.05M | 0.01% | 1042 |
|
|
2020
Q1 | $15.3M | Sell |
848,614
-37,748
| -4% | -$716K | 0.01% | 1185 |
|
|
2019
Q4 | $15.7M | Sell |
886,362
-18,584
| -2% | -$322K | 0.01% | 1380 |
|
|
2019
Q3 | $14M | Buy |
904,946
+19,593
| +2% | +$323K | 0.01% | 1380 |
|
|
2019
Q2 | $15.2M | Buy |
885,353
+44,072
| +5% | +$711K | 0.01% | 1327 |
|
|
2019
Q1 | $13.5M | Buy |
841,281
+146,198
| +21% | +$2.37M | 0.01% | 1385 |
|
|
2018
Q4 | $10.2M | Sell |
695,083
-245,209
| -26% | -$3.91M | 0.01% | 1450 |
|
|
2018
Q3 | $17.1M | Sell |
940,292
-58,968
| -6% | -$1.03M | 0.01% | 1251 |
|
|
2018
Q2 | $16.9M | Buy |
999,260
+72,392
| +8% | +$1.37M | 0.01% | 1219 |
|
|
2018
Q1 | $18.2M | Buy |
926,868
+265,855
| +40% | +$5.15M | 0.01% | 1070 |
|
|
2017
Q4 | $13.4M | Buy |
661,013
+90,500
| +16% | +$1.66M | 0.01% | 1285 |
|
|
2017
Q3 | $9.91M | Buy |
570,513
+58,707
| +11% | +$795K | 0.01% | 1437 |
|
|
2017
Q2 | $6.56M | Buy |
511,806
+46,040
| +10% | +$615K | 0.01% | 1647 |
|
|
2017
Q1 | $6.04M | Sell |
465,766
-4,726
| -1% | -$59.7K | 0.01% | 1646 |
|
|
2016
Q4 | $4.65M | Buy |
470,492
+37,841
| +9% | +$414K | 0.01% | 1786 |
|
|
2016
Q3 | $5.23M | Buy |
432,651
+59,009
| +16% | +$603K | 0.01% | 1623 |
|
|
2016
Q2 | $3.23M | Sell |
373,642
-67,293
| -15% | -$664K | ﹤0.01% | 1833 |
|
|
2016
Q1 | $4.18M | Sell |
440,935
-14,695
| -3% | -$138K | 0.01% | 1634 |
|
|
2015
Q4 | $7.9M | Buy |
455,630
+28,435
| +7% | +$453K | 0.01% | 1180 |
|
|
2015
Q3 | $5.74M | Buy |
427,195
+58,820
| +16% | +$1.18M | 0.01% | 1378 |
|
|
2015
Q2 | $8.32M | Buy |
368,375
+57,020
| +18% | +$1M | 0.01% | 1181 |
|
|
2015
Q1 | $4.45M | Buy |
311,355
+14,934
| +5% | +$215K | 0.01% | 1583 |
|
|
2014
Q4 | $2.86M | Buy |
296,421
+9,994
| +3% | +$88.8K | ﹤0.01% | 1808 |
|
|
2014
Q3 | $2.61M | Buy |
286,427
+6,244
| +2% | +$59.5K | ﹤0.01% | 1810 |
|
|
2014
Q2 | $2.77M | Buy |
280,183
+9,136
| +3% | +$77.5K | ﹤0.01% | 1799 |
|
|
2014
Q1 | $3.44M | Buy |
271,047
+23,873
| +10% | +$354K | 0.01% | 1616 |
|
|
2013
Q4 | $3.71M | Buy |
247,174
+18,914
| +8% | +$243K | 0.01% | 1499 |
|
|
2013
Q3 | $2.52M | Buy |
228,260
+21,777
| +11% | +$181K | 0.01% | 1703 |
|
|
2013
Q2 | $1.59M | Buy |
+206,483
| New | +$1.32M | ﹤0.01% | 1898 |
|
Other funds holding HALO
Charles Schwab's HALO Position: Q2 2026 in Review
Charles Schwab increased its Halozyme (HALO) stake by 2.6% in Q2 2026, buying an estimated $2.26M and bringing the position to 1,322,613 shares worth $104M. The position accounts for 0.01% of the portfolio, ranked #781.
Charles Schwab first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. The position peaked at $112M in Q1 2025. 666 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Charles Schwab held 1,322,613 shares of Halozyme worth $104M as of Q2 2026.
- Charles Schwab bought 33,080 Halozyme shares in Q2 2026, an estimated $2.26M.
- Halozyme made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #781 holding.
- Charles Schwab first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Halozyme position peaked at $112M in Q1 2025.
- 666 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.